Physician profile
Mark Goldberger
NPI 1740277425
$5,201.29
in general payments reported to CMS, 2019-2025
45 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $454 · 2021: $312 · 2022: $1,667 · 2023: $444 · 2024: $313 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,530.67 | 2019-2024 | Everest Spinal System, Capri Corpectomy Cage System |
| Medtronic, INC. | $347.54 | 2022-2025 | Mazor X System, Inceptiv, Accurian |
| Nevro Corp. | $290.17 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $269.68 | 2022-2025 | Cervical-Stim, M6-C, Newbridge |
| Boston Scientific Corporation | $182.99 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Spinal Elements, INC. | $169.76 | 2019-2021 | |
| Si-Bone, INC. | $138.29 | 2020-2025 | |
| Scilex Pharmaceuticals INC. | $109.15 | 2021-2023 | Ztlido |
| Abbvie INC. | $87.06 | 2021-2023 | |
| Abbott Laboratories | $85.01 | 2019-2025 | Proclaim |
| Globus Medical, INC. | $74.65 | 2025 | Senza, Corridor |
| Bioventus LLC | $68.96 | 2019-2025 | Sonastar, Bonescalpel & Sonicone (O.R.) |
| Depuy Synthes Sales INC. | $65.25 | 2019-2025 | Synthecel |
| Intrinsic Therapeutics | $64.63 | 2022 | |
| Medtronic USA, INC. | $53.93 | 2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Goldberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.